High level a general overview

Active compound: clonidine.

Typical indication: oral clonidine and, when available, transdermal formulations are used to treat raised arterial blood pressure. A clinician may prescribe it alone or together with other antihypertensive medicines depending on the clinical situation.

  • Common tablet strength encountered in Australian practice is 0.1 mg (100 microgram) tablets.
  • When transdermal patches are sourced, they usually deliver the drug over seven days and sometimes require a special order.
  • Clonidine is a prescription-only medicine in Australia and must be dispensed with a valid prescription from a registered Australian prescriber.

See a professional for advice the sections on dosing (how the dose is administered) and safety (safety measures and safety guidelines) for more detail.

Navigate back to the page top

An outline of what clonidine is

Clonidine is a centrally acting antihypertensive medication. Administered orally or via a skin patch, it reduces sympathetic nervous system activity to lower blood pressure.

It may be used as single agent therapy or combined with other blood pressure medicines. Some off-label uses exist but should only be considered after specialist review and clear clinical justification.

Go to top

How it manifests its actions

The main a device is stimulation of alpha-2 adrenoceptors in the brain stem, which decreases sympathetic outflow. This results in vasodilation, a tendency toward a slower heart rate, and a lowering of blood pressure.

This central mode of action also explains common effects on the central nervous system such as sedation and reduced alertness; refer to the safety section for advice about driving and operating machinery.

Scroll to top

Dosing and administration protocol

Only a prescriber who knows your medical history should set the dose. The examples below describe patterns used clinically and are not a substitute for personalised medical instructions.

  • Oral tablets: a typical starting plan for adults is 0.1 mg (100 microgram) twice daily, with gradual titration based on blood pressure response and tolerability. Some patients concentrate a larger portion of the dose at night to reduce daytime drowsiness.
  • Transdermal patches: place on clean, dry, hairless skin on the upper arm or torso. Replace every seven days and rotate application sites to reduce local skin irritation.
  • Stopping therapy: do not discontinue clonidine suddenly. A supervised taper is advised to avoid rebound hypertension and withdrawal symptoms.

If you have questions about your particular product or a dose was misseds, consult your pharmacist or prescriber and see the i did not take my prescribed doses and a fatal overdose a portion of the text.

Open to page the pinnacle of the page

Guarding measures and safety measures

Before you commence clonidine, tell your prescriber about kidney problems, fainting episodes, slow or irregular heartbeat, recent heart attack, poor peripheral circulation such as Raynaud phenomenon, or a history of mood disorders.

  • Avoid or limit alcohol and be careful with other sedating medicines since clonidine can impair concentration and coordination.
  • From conception to lactation: discuss benefits and risks through your clinician. Additional options such as methyldopa are often preferred in pregnancy after specialist consultation.
  • Do not stop the drug abruptly; seek medical advice for a proper tapering plan to reduce the risk of rebound effects such as severe hypertension, tremor and agitation.

If you drive, use heavy machinery or perform safety-critical workwould you mind checking this? with your clinician about fitness for these activities while taking clonidine. For workplace and driving rules see the legal eligibility status and import next section.

Jump back to the first place

Safety procedures and situations where this treatment is not advised and Advisory Cautions

Do not use clonidine if you have a known allergy to clonidine or any ingredient in the product.

  • Avoid in patients with significant bradycardia, sick sinus syndrome or high-grade atrioventricular block unless a functioning pacemaker is present.
  • Exercise caution and seek specialist guidance when clonidine is considered in unstable coronary disease, recent myocardial infarction, or advanced renal impairment.

When special caution is required, initiation and monitoring should be performed by healthcare professionals experienced in managing complex cardiovascular conditions.

Go to top

Possible reactions to the medication

Some adverse effects require urgent medical attention. Seek emergency help for signs of an allergic reaction such as swelling of the face, lips, tongue or throat, or difficulty breathing.

Common and less common reactions include:

  • Dry mouth condition, sleepiness, lightheadedness, constipation and general tiredness.
  • Cardiovascular effects including slow heart rate, palpitations and fluid retention causing peripheral swelling.
  • Neuropsychiatric effects such as confusion, mood changes and, rarely, hallucinations.
  • Urinary complaints: some people report reduced urine output or difficulty voiding.

If harmful consequences are persistent or troublesome, contact your prescriber. They may change the dose or suggest a different medicine; see substitute options.

Go to the first place of the page

Therapeutic medication-drug the act of connecting with others advisories

Clonidine interacts with a number of medicines and substances. Always provide a full list of prescription medicines, over-the-counter products, vitamins and herbal remedies to your prescriber and pharmacist.

  • Other central nervous system depressants such as alcohol, opioids and benzodiazepines can increase sedation and, in some cases, respiratory depression.
  • Tricyclic antidepressants may blunt clonidine's antihypertensive effect.
  • Concurrent use with heart rate lowering medicines like beta blockers may increase the chance of symptomatic bradycardia; any changes should be supervised by a clinician.
  • Immunosuppressants such as cyclosporine may interact and alter renal risk in susceptible patients, so ongoing monitoring is advised.

When starting or stopping drugs that affect blood pressure or heart rate, do so only with medical advice to reduce the risk of rebound hypertension or excessive bradycardia.

Return again to page top

Failed adherence and an opioid overdose risk

Missed tablet: take the i missed a dose as soon as you remember unless the next dose is close. Do not take two doses simultaneously to replace a i missed a dose.

Missed patch change: apply a new patch as soon as you notice and reset your weekly schedule. If unsure, contact your pharmacist for advice.

How to spot an a drug overdose case: severe drowsiness, marked low blood pressure, very slow pulse, shallow breathing, fainting or unconsciousness. An a drug overdose case can sometimes begin with an unexpected rise in blood pressure and a severe cranial pain before progressing to low blood pressure and bradycardia.

If you suspect an overdose case, phone emergency services or go ahead to the nearest emergency department without delay.

Return to the starting point the tip top of the page

Store and handle

Keep tablets and patches at normal room temperature, ideally between 15 and 30 C. Avoid excess heat, damp conditions and direct sunlight. Place it in a locked cabinet out of reach of children and pets.

Dispose of used patches carefully so that children or animals cannot access them. If you need guidance on disposalplease audit this. the product leaflet or ask your pharmacist.

Go to top

Substitute therapies and comparable drugs

If clonidine is unsuitable due to negative effects or contraindicating factors in clinical decisions, several other classes of blood pressure medicines are available. The best option depends on overall health, comorbidities and broad potential effective collaborative interactions require clear communication..

  • Thiazide diuretics: e.g., hydrochlorothiazide, indapamide.
  • ACE inhibitors: e.g., enalapril, perindopril, ramipril.
  • Angiotensin receptor blockers (ARBs): e.g., losartan, irbesartan, candesartan.
  • Calcium channel blockers: e.g., amlodipine, diltiazem.
  • Beta blockers: e.g., metoprolol, bisoprolol.
  • Other centrally acting agents: moxonidine, methyldopa and extended-release guanfacine in selected cases.

Brief comparisons:

  • Moxonidine predominantly targets imidazoline receptors and may cause fewer central secondary effects in some patients compared with clonidine.
  • Methyldopa is often chosen in pregnancy after specialist advice because of a longer safety record in that setting.
  • Extended-release guanfacine is mainly used for attention deficit hyperactivity disorder; its role as an antihypertensive in Australia is limited.

Discuss therapeutic choices with your health care provider. For relative prices and subsidy information see the pricing and legal section groupings.

Navigate back to page top

Price estimates for Australia in AUD

Retail prices vary by pharmacy, brand, pack size and whether the product is subsidised through the Pharmaceutical Benefits Scheme (PBS). The figures below are only approximate private retail ranges and may change.

  • Clonidine 100 microgram tablets, pack of 100: approximately AUD 8 to 25 privately depending on brand and supplier.
  • Clonidine weekly transdermal patches, pack of 4 (special order): roughly AUD 40 to 90 privately.
  • Prices for comparable antihypertensives (private retail examples):
    • Amlodipine 5 mg, 30 tablets: about AUD 5 to 20.
    • Losartan potassium is the active compound 50 mg, 30 tablets: about AUD 6 to 25.
    • Hydrochlorothiazide 25 mg, 50 tablets: about AUD 4 to 15.
    • Moxonidine 0.2 mg, 30 tablets: about AUD 10 to 30.

Ask your pharmacist about current private prices and whether the PBS or concession rates apply to your prescription. For some patients PBS listing will mean a lower co-payment than the private price.

Return to the location the crown

Additional aspects about Clonidine